Our data showed a trend towards having lower ER and PR immunoreactive scores in tumors that have low BRCA1 expression which is in agreement with previous studies showing BRCA1-related breast cancers are more frequently ER negative than nonhereditary breast cancers [30]. This evidence concerns the gene PGR and breast carcinoma.